Danaher Corp (NYSE:DHR)
$ 234.34 -1.57 (-0.67%) Market Cap: 170.39 Bil Enterprise Value: 181.11 Bil PE Ratio: 45.02 PB Ratio: 3.32 GF Score: 87/100

Danaher Corp at JPMorgan Healthcare Conference Transcript

Jan 14, 2020 / 04:00PM GMT
Release Date Price: $143.05 (+1.14%)
Tycho W. Peterson
JP Morgan Chase & Co, Research Division - Senior Analyst

Okay. We're going to go ahead and kick it off. I'm Tycho Peterson from the life science team at JPMorgan. Welcome to day 2 of the conference. I'm here to introduce Danaher. We'll do a breakout right after in the Georgian Room across the hall.

With that, let me turn it over to Tom Joyce.

Thomas P. Joyce
Danaher Corporation - CEO, President & Director

Thank you, Tycho, and thank you to the entire JPMorgan team for putting on what I know, again, will be a terrific conference. Thanks to all of you also for joining us, all of you who rose to the early bell this morning for the 8:00 session. We appreciate you all joining us.

Here are our forward-looking statements. Obviously, I will let you read those at your leisure. Maybe before we dive in, I think many of you probably saw the announcement that we put out yesterday. An announcement around a preliminary look at our fourth quarter. And as you saw from that announcement, and I'll recap here, appears that we had a

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot